Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group

OBJECTIVE: To provide clinical management guidelines for eyes with central retinal vein occlusion. DESIGN: Prospective cohort study with randomized clinical trials of specific subgroups of patients. Three-year follow-up every 4 months. SETTING: Nine ophthalmology practices. PATIENTS: Seven hundred twenty-five patients with central vein occlusion. MAIN OUTCOME MEASURES: Iris neovascularization (INV), neovascular glaucoma, and visual acuity. RESULTS: Visual acuity outcome was largely dependent on initial acuity. Sixty-five percent of patients with initially good visual acuity (20/40 or better) maintained visual acuity in the same range at the end of the study. Patients with intermediate initial acuity (20/50-20/200) showed a variable outcome: 19% improved to better than 20/50, 44% stayed in the intermediate group, and 37% had final visual acuity worse than 20/200. Patients who had poor visual acuity at the first visit (< 20/200) had an 80% chance of having a visual acuity less than 20/200 at final visit, whether perfused or nonperfused initially. In the first 4 months of follow-up, 81 (15%) of the 547 eyes with perfusion converted to ischemia. During the next 32 months of follow-up, an additional 19% of eyes were found to have converted to ischemia for a total of 34% after 3 years. The development of nonperfusion or ischemia was most rapid in the first 4 months and progressed continuously throughout the entire duration of follow-up. Iris neovascularization of at least 2-clock hours, and/or angle neovascularization (ANV) developed in 117 (16%) of the 714 eyes. Sixty-one of the 117 eyes that had INV/ANV were initially categorized as nonperfused or indeterminate; 56 of the 117 eyes were initially categorized as perfused. When INV/ANV occurred, it was treated promptly with panretinal photocoagulation. The strongest predictors of INV/ANV were visual acuity (P < .001) and the amount of nonperfusion seen by fluorescein angiogram (P < .001). For eyes initially categorized as nonperfused or indeterminate, 35% (61/176) developed INV/ANV, compared with 10% (56/538) for eyes initially categorized as perfused. Other risk factors were venous tortuosity (P = .02), extensive retinal hemorrhage (P = .07), and duration less than 1 month (P = .08). Neovascular glaucoma that was unsuccessfully managed with medical treatment developed in only 10 eyes. No eye was enucleated. CONCLUSIONS: Visual acuity at baseline is a strong predictor of visual acuity at 3 years for eyes with good vision and eyes with poor vision, but a poor predictor for intermediate acuities. Visual acuity is also a strong predictor for the development of INV/ANV, as is nonperfusion. During the course of follow-up, one third of the eyes with perfusion converted to eyes with ischemia. Clinical management guidelines, developed from these and previously reported Central Vein Occlusion Study data, are presented.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ocular Associations of Diabetes Other Than Diabetic Retinopathy
Jeganathan et al.
Diabetes Care 2008;31:1905-1912.
FULL TEXT  

Retinal arterial and venous occlusions in patients with ADPKD
Qian et al.
Nephrol Dial Transplant 2007;22:1769-1771.
FULL TEXT  

Lamina Puncture for Central Retinal Vein Occlusion: Results of a Pilot Trial
D'Amico et al.
Arch Ophthalmol 2006;124:972-977.
ABSTRACT | FULL TEXT  

The management of retinal vein occlusion: is interventional ophthalmology the way forward?
Shahid et al.
Br. J. Ophthalmol. 2006;90:627-639.
ABSTRACT | FULL TEXT  

A review of developments in the management of retinal diseases.
Banerjee
JRSM 2006;99:125-127.
FULL TEXT  

Fundus and Histopathological Study of Radial Optic Neurotomy in the Normal Miniature Pig Eye
Tao et al.
Arch Ophthalmol 2005;123:1097-1101.
ABSTRACT | FULL TEXT  

Early chorioretinal anastomosis in non-ischaemic CRVO: a randomised trial
Antcliff et al.
Br. J. Ophthalmol. 2005;89:780-781.
FULL TEXT  

Radial optic neurotomy for ischaemic central vein occlusion
Martinez-Jardon et al.
Br. J. Ophthalmol. 2005;89:558-561.
ABSTRACT | FULL TEXT  

New Therapy for Central Retinal Vein Occlusion: Are Intravitreal Steroids a Possible Answer?
Blumenkranz
Arch Ophthalmol 2005;123:259-261.
FULL TEXT  

The Question of Radial Optic Neurotomy in Central Retinal Vein Occlusion
Malhotra et al.
Arch Ophthalmol 2004;122:1573-1574.
FULL TEXT  

The Question of Radial Optic Neurotomy in Central Retinal Vein Occlusion--Reply
Garcia-Arumi
Arch Ophthalmol 2004;122:1574-1575.
FULL TEXT  

Intravitreal Triamcinolone for the Treatment of Macular Edema Associated With Central Retinal Vein Occlusion
Ip et al.
Arch Ophthalmol 2004;122:1131-1136.
ABSTRACT | FULL TEXT  

Radial Optic Neurotomy in the Porcine Eye Without Retinal Vein Occlusion
Czajka et al.
Arch Ophthalmol 2004;122:1185-1189.
ABSTRACT | FULL TEXT  

Clinical Course of Younger Patients With Central Retinal Vein Occlusion
Recchia et al.
Arch Ophthalmol 2004;122:317-321.
ABSTRACT | FULL TEXT  

Chorioretinal Anastomosis After Radial Optic Neurotomy for Central Retinal Vein Occlusion
Garcia-Arumi et al.
Arch Ophthalmol 2003;121:1385-1391.
ABSTRACT | FULL TEXT  

Vision-Related Quality of Life in People With Central Retinal Vein Occlusion Using the 25-Item National Eye Institute Visual Function Questionnaire
Deramo et al.
Arch Ophthalmol 2003;121:1297-1302.
ABSTRACT | FULL TEXT  

A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion
Williamson et al.
Br. J. Ophthalmol. 2003;87:1126-1129.
ABSTRACT | FULL TEXT  

Retinochoroidal Collateral Veins Protect Against Anterior Segment Neovascularization After Central Retinal Vein Occlusion
Fuller et al.
Arch Ophthalmol 2003;121:332-336.
ABSTRACT | FULL TEXT  

Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year
Arsene et al.
Br. J. Ophthalmol. 2002;86:1243-1247.
ABSTRACT | FULL TEXT  

Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion
Larsson and Andreasson
Br. J. Ophthalmol. 2001;85:683-685.
ABSTRACT | FULL TEXT  

Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion
Paques et al.
Br. J. Ophthalmol. 2000;84:1387-1391.
ABSTRACT | FULL TEXT  

Pattern of Vascular Nonperfusion in Retinal Venous Occlusions Occurring Within the Optic Nerve With and Without Optic Nerve Head Swelling
Beaumont and Kang
Arch Ophthalmol 2000;118:1357-1363.
ABSTRACT | FULL TEXT  

Superselective Ophthalmic Arterial Fibrinolysis with Urokinase for Recent Severe Central Retinal Venous Occlusion: Initial Experience
Vallée et al.
Radiology 2000;216:47-53.
ABSTRACT | FULL TEXT  

Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study
Glacet-Bernard et al.
Br. J. Ophthalmol. 2000;84:609-613.
ABSTRACT | FULL TEXT  

A Study of Surgical Approaches to Retinal Vascular Occlusions
Tang and Han
Arch Ophthalmol 2000;118:138-143.
ABSTRACT | FULL TEXT  

Laser-Induced Chorioretinal Anastomosis and Central Retinal Vein Occlusion
Parodi et al.
Arch Ophthalmol 1999;117:140-141.
FULL TEXT  

Bilateral Central Retinal Vein Occlusions
Sanborn and Clarkson
Arch Ophthalmol 1998;116:260-261.
FULL TEXT  

Laser-Induced Chorioretinal Venous Anastomosis for Nonischemic Central or Branch Retinal Vein Occlusion
Fekrat et al.
Arch Ophthalmol 1998;116:43-52.
ABSTRACT | FULL TEXT  

Combined Central Retinal Arterial and Venous Obstruction: Emergency Ophthalmic Arterial Fibrinolysis
Vallee et al.
Radiology 2002;223:351-359.
ABSTRACT | FULL TEXT